Interestingly, the authors showed downregulation of NCAM1 expression in the hippocampus of early-stage AD, as well as of NCAM1, TUBB, and RBFOX3 in late-stage AD, which is in line with our results after the addition of Aβ to the culture. The gene discussed is NCAM1; the disease is Alzheimer disease.